RNS Number:0967N
Vision Opportunity China Fund Ltd
01 February 2008


   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES,
              CANADA, AUSTRALIA, REPUBLIC OF SOUTH AFRICA OR JAPAN

1 February 2008

                     Vision Opportunity China Fund Limited

                                Third Investment

Vision Opportunity China Fund Limited ("VOC") (AIM:VOC.L) announces the
completion of its third investment since listing on the AIM market ("AIM"). VOC
has invested $2 million as part of a $25 million financing for China Sky One
Medical, Inc., (OTCBB:CSKI), a manufacturer, marketer and distributor of
pharmaceutical, medicinal and diagnostic products in China.

In return for its investment, VOC received the following:

(a) 200,000 shares of common stock, and

(b) 3 year warrants to purchase 60,000 shares of CSKI's common stock at an
exercise price of $12.50 per share exercisable from July 2008. The closing price
of OTCBB: CSKI's common stock on January 31, 2008 was $12.10.

This transaction is described in more detail in the 8-K and other supporting
documents filed by CSKI with the Securities and Exchange Commission.

"The pharmaceutical industry in China has been experiencing exponential growth
and we believe that this trend will continue in the foreseeable future. CSKI has
a diverse product portfolio as well as an extensive sales and marketing team.
With this financing and the intended acquisitions, the company will be able to
leverage its platform to further expand and diversify its product portfolio and
to capitalise on favorable market conditions and industry dynamics." stated Adam
Benowitz, the portfolio manager of VOC at Vision Capital Advisors, LLC.


Enquiries to:


Vision Opportunity China Fund Limited
David Benway, Director / Adam Benowitz, Portfolio Manager

www.vocfund.com                     Tel: +1 (212) 849 8225


Fairfax I.S. PLC
Paul Richards/ James King           Tel: +44 (0) 20 7598 5368


Bankside Consultants Limited
Simon Rothschild/Oliver Winters     Tel: +44 (0) 20 7367 8888


NOTE TO EDITORS

Vision Opportunity China Fund Limited

Vision Opportunity China Fund Limited ("VOC") is a closed-ended listed fund
traded on AIM. VOC primarily invests directly in listed companies with
operations principally within Greater China.

Greater China is a collective term for the territories administered by the
People's

Republic of China, those administered by the Republic of China and Singapore.


China Sky One Medical, Inc. (CSKI)

China Sky One Medical, Inc., a Nevada corporation, is a holding company whose
principal operations are through its subsidiaries, which are engaged in the
manufacturing, marketing and distribution of pharmaceutical, medicinal and
diagnostic kit products in China. Through its wholly-owned subsidiaries, Harbin
Tian Di Ren Medical Science and Technology Company ("TDR") and Harbin First
Bio-Engineering Company Limited ("First"), CSKI's principal revenue source is
the manufacture and sale of over-the-counter pharmaceutical products.






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCILFVLFDILIIT
Vision OP China (LSE:VOC)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Vision OP China Charts.
Vision OP China (LSE:VOC)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Vision OP China Charts.